Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jasminum fruticans methanol extract
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jasminum fruticans methanol extract is a botanical preparation derived from the wild jasmine plant, native to the Mediterranean and Turkey. It contains a variety of bioactive phytochemicals, including phenolic compounds and flavonoids. In preclinical studies, the extract has demonstrated antioxidant properties through radical scavenging and anti-inflammatory activity by reducing the production of nitric oxide, tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and prostaglandin E2 (PGE2). Additionally, it has shown cytotoxic effects against DU145 prostate cancer and A549 lung cancer cell lines, suggesting potential applications in oncology and inflammatory disorders.
- Other names
- Jasminum fruticans extractWild Jasmine extract
Beyond the preview
Go deeper on jasminum fruticans methanol extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jasminum fruticans methanol extract.